Clinical trial
Naratriptan for the Treatment of Post Traumatic Headache Associated With…
NCT00487578 · Cady, Roger, M.D., Other · Terminated
Key facts
| NCT number | NCT00487578 |
|---|---|
| Title | Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction |
| Official title | Evaluation of the Efficacy of Naratriptan for the Treatment and Prevention of Post Traumatic Headache Associated With Cognitive Dysfunction |
| Lead sponsor | Cady, Roger, M.D., Other |
| Collaborators | GlaxoSmithKline Industry Clinvest |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Post Traumatic Headache |
| Intervention type | Drug |
| Interventions | naratriptan HCl |
| Enrollment | 12 |
| Start date | Oct 1, 2006 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Jun 18, 2007 |
| Last update posted | Feb 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: